Blood pressure measurement prior to initiating hormonal contraception: A systematic review

Contraception

Volumn 87, Issue 5, 2013, Pages 631-638

  Tepper, Naomi K ^a   Curtis, Kathryn M ^a   Steenland, Maria W ^a   Marchbanks, Polly A ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

Blood pressure; Hormonal contraception; Systematic review

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ACUTE HEART INFARCTION; BLOOD PRESSURE MEASUREMENT; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CASE CONTROL STUDY; HORMONAL CONTRACEPTION; HUMAN; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; WORLD HEALTH ORGANIZATION;

BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; HUMANS; HYPERTENSION; MYOCARDIAL INFARCTION; STROKE;

EID: 84876666315     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2012.08.025     Document Type: Review

References (13)

1. K.M. Curtis, A.P. Mohllajee, S.L. Martins, and H.B. Peterson Combined oral contraceptive use among women with hypertension: A systematic review Contraception 73 2006 179 188 (Pubitemid 43087767)
2. L.A. Heinemann, A. Assmann, T. DoMinh, and E. Garbe Oral progestogen-only contraceptives and cardiovascular risk: results from the Transnational Study on Oral Contraceptives and the Health of Young Women Eur J Contracept Reprod Health Care 4 1999 67 73 (Pubitemid 29318065)
3. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case-control study Contraception 57 1998 315 324
4. Centers for Disease Control and Prevention U.S. Medical Eligibility Criteria for Contraceptive Use, 2010 MMWR Recomm Rep 59 RR-4 2010 1 86
5. R.P. Harris, M. Helfand, and S.H. Woolf Current methods of the US Preventive Services Task Force: A review of the process Am J Prev Med 20 2001 21 35 (Pubitemid 33732964)
6. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study. Lancet 349 1997 1202 1209
7. M.A. Lewis, L.A. Heinemann, W.O. Spitzer, K.D. MacRae, and R. Bruppacher The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women Contraception 56 1997 129 140 (Pubitemid 27450822)
8. N. Dunn, M. Thorogood, B. Faragher, L. de Caestecker, T.M. MacDonald, and C. McCollum Oral contraceptives and myocardial infarction: results of the MICA case-control study BMJ 318 1999 1579 1583
9. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception Ischaemic stroke and combined oral contraceptives: results of an international, multicentre, case-control study Lancet 348 1996 498 505
10. L.A. Heinemann, M.A. Lewis, W.O. Spitzer, M. Thorogood, I. Guggenmoos-Holzmann, and R. Bruppacher Thromboembolic stroke in young women. A European case-control study on oral contraceptives. Transnational Research Group on Oral Contraceptives and the Health of Young Women Contraception 57 1998 29 37 (Pubitemid 28160432)
11. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: results of an international, multicentre, case-control study Lancet 348 1996 505 510
12. L.A. Heinemann, M.A. Lewis, M. Thorogood, W.O. Spitzer, I. Guggenmoos-Holzmann, and R. Bruppacher Case-control study of oral contraceptives and risk of thromboembolic stroke: results from International Study on Oral Contraceptives and Health of Young Women BMJ 315 1997 1502 1504 (Pubitemid 27517177)
13. N.R. Dunn, M. Thorogood, L. de Caestecker, and R.D. Mann Myocardial infarction and oral contraceptives, a retrospective case control study in England and Scotland ('MICA' Study) Pharmacoepidemiol Drug Saf 6 1997 283 289 (Pubitemid 27414432)